CRISPR-Cas9 gene editing trial results support further development as treatment for hereditary angioedema
A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...
technologynetworks5h
CRISPR-Cas9 Therapy Shows Promise As Single-Dose Treatment for Hereditary Angioedema
Researchers expand on their phase one study demonstrating a single treatment with a CRISPR-Cas9-based gene editing therapy, ...
Armed robbery in Revesby9h
CRISPR-Cas9 Phase 2 Boosts Hereditary Angioedema Hope
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with ...
FierceBiotech3h
Poseida's HAE gene therapy edits primate livers and reduces kallikrein protein levels in mice, company says
Poseida Therapeutics’ gene therapy for hereditary angioedema (HAE) reduced kallikrein protein activity in a mouse model of ...
healthday5h
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regul ...
Bulletin of the Atomic Scientists14d
CRISPR therapies can treat disease but cost millions. An equity-based approach could bring them to more people
New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.
A Closer Look at Intellia Therapeutics's Options Market Dynamics
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $17.5 to $20.0 for Intellia Therapeutics over the recent three months.
Nature7d
CRISPR-Cas9 genome editing articles from across Nature Portfolio
CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...
EurekAlert!9mon
Revamping Chinese cabbage: CRISPR edits for healthier flavonoids
Scientists have leveraged CRISPR/Cas9 gene editing to enhance the nutritional properties of Chinese cabbage. By targeting the ...
C&EN11dOpinion
Editorial: Gene editing is an opportunity for chemistry’s good governance
In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...
EurekAlert!8h
Phase Two results with CRISPR-Cas9 gene editing support further development as treatment for hereditary angioedema (HAE)
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...